A nonspecific-treatment control group
a) Is designed to control for common factors that are associated with treatment
b) Rules out the role of expectancies in explaining why clients get better
c) Controls for placebo effects in a medication study
d) Is the best way to rule out threats to internal validity (e.g., regression, testing)
Question 2Why are waiting-list control groups more favorable than no-treatment control groups?
a) They allow for both between and within-participant comparisons.
b) Every participant will receive the treatment at the same time.
c) It eliminates all ethical concerns for methodology.
d) The control group is not impacted by contact with the experiment.
Question 3Why are no-treatment control groups problematic?
a) They do not account for individual differences in outcomes.
b) They are difficult to ethically justify.
c) They are not typically based upon strict protocols.
d) They do not allow for random assignment.
Question 4Spontaneous remission is a problem in therapy studies because
a) Participants change overtime without being in a treatment condition.
b) It is a threat to the external validity of the experiment.
c) It does not provide a necessary baseline for comparison.
d) It does not utilize at least one control group.
Question 5Control groups are typically used to address threats to
a) External validity
b) Ecological validity
c) Construct validity
d) Internal validity
Quick Reply
